Zev A. Wainberg, MD Updates in Gastrointestinal Cancers @MOASC_Office @dgsomucla

Zev A. Wainberg, MD Updates in Gastrointestinal Cancers @MOASC_Office @dgsomucla

User Photo
moasc

5 months
43 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Zev A. Wainberg, MD Associate Professor Of Medicine Co-Director GI Oncology Program David Geffen School of Medicine at UCLA gives an update in Gastrointestinal Cancers including KEYNOTE-059, Pembrolizumab, MSI-H KN 059, MSI-H KN 059 061, KEYNOTE 181, KEYNOTE-062, KEYNOTE 59, KEYNOTE-811, CHECKMATE-649, Javelin Gastric 100, SPOTLIGHT (FAST-2) 1L Claudin+, FIGHT 1L FGFR2, PRODIGE 24/CCTG PA.6 trial at the MOASC Summit 2020

Sponsors:

AbbVie 

AMAG

AstraZeneca 

Bayer 

BeiGene 

Clovis Oncology

Coherus 

Daiichi-Sankyo 

Dova Pharmaceuticals 

Foundation Medicine 

Jazz Pharmaceuticals  

Merck 

Pfizer Oncology 

Puma Biotechnology 

Tempus 

Verastem oncology

Walgreens 

Up Next Autoplay